180 related articles for article (PubMed ID: 21902278)
21. Considerations in compound database preparation--"hidden" impact on virtual screening results.
Knox AJ; Meegan MJ; Carta G; Lloyd DG
J Chem Inf Model; 2005; 45(6):1908-19. PubMed ID: 16309298
[TBL] [Abstract][Full Text] [Related]
22. New fragment weighting scheme for the Bayesian inference network in ligand-based virtual screening.
Abdo A; Salim N
J Chem Inf Model; 2011 Jan; 51(1):25-32. PubMed ID: 21155550
[TBL] [Abstract][Full Text] [Related]
23. Virtual drug screen schema based on multiview similarity integration and ranking aggregation.
Kang H; Sheng Z; Zhu R; Huang Q; Liu Q; Cao Z
J Chem Inf Model; 2012 Mar; 52(3):834-43. PubMed ID: 22332590
[TBL] [Abstract][Full Text] [Related]
24. Efficient virtual screening using multiple protein conformations described as negative images of the ligand-binding site.
Virtanen SI; Pentikäinen OT
J Chem Inf Model; 2010 Jun; 50(6):1005-11. PubMed ID: 20504004
[TBL] [Abstract][Full Text] [Related]
25. Benchmarking Data Sets for the Evaluation of Virtual Ligand Screening Methods: Review and Perspectives.
Lagarde N; Zagury JF; Montes M
J Chem Inf Model; 2015 Jul; 55(7):1297-307. PubMed ID: 26038804
[TBL] [Abstract][Full Text] [Related]
26. Analysis and comparison of 2D fingerprints: insights into database screening performance using eight fingerprint methods.
Duan J; Dixon SL; Lowrie JF; Sherman W
J Mol Graph Model; 2010 Sep; 29(2):157-70. PubMed ID: 20579912
[TBL] [Abstract][Full Text] [Related]
27. Virtual screening for ligands of the insect molting hormone receptor.
Harada T; Nakagawa Y; Ogura T; Yamada Y; Ohe T; Miyagawa H
J Chem Inf Model; 2011 Feb; 51(2):296-305. PubMed ID: 21275397
[TBL] [Abstract][Full Text] [Related]
28. Introduction of the conditional correlated Bernoulli model of similarity value distributions and its application to the prospective prediction of fingerprint search performance.
Vogt M; Bajorath J
J Chem Inf Model; 2011 Oct; 51(10):2496-506. PubMed ID: 21892818
[TBL] [Abstract][Full Text] [Related]
29. Ligand-target interaction-based weighting of substructures for virtual screening.
Crisman TJ; Sisay MT; Bajorath J
J Chem Inf Model; 2008 Oct; 48(10):1955-64. PubMed ID: 18821751
[TBL] [Abstract][Full Text] [Related]
30. The effect of ligand-based tautomer and protomer prediction on structure-based virtual screening.
Kalliokoski T; Salo HS; Lahtela-Kakkonen M; Poso A
J Chem Inf Model; 2009 Dec; 49(12):2742-8. PubMed ID: 19928753
[TBL] [Abstract][Full Text] [Related]
31. Integrating virtual screening in lead discovery.
Oprea TI; Matter H
Curr Opin Chem Biol; 2004 Aug; 8(4):349-58. PubMed ID: 15288243
[TBL] [Abstract][Full Text] [Related]
32. Development of a method to consistently quantify the structural distance between scaffolds and to assess scaffold hopping potential.
Li R; Stumpfe D; Vogt M; Geppert H; Bajorath J
J Chem Inf Model; 2011 Oct; 51(10):2507-14. PubMed ID: 21955025
[TBL] [Abstract][Full Text] [Related]
33. Discovery of novel Pim-1 kinase inhibitors by a hierarchical multistage virtual screening approach based on SVM model, pharmacophore, and molecular docking.
Ren JX; Li LL; Zheng RL; Xie HZ; Cao ZX; Feng S; Pan YL; Chen X; Wei YQ; Yang SY
J Chem Inf Model; 2011 Jun; 51(6):1364-75. PubMed ID: 21618971
[TBL] [Abstract][Full Text] [Related]
34. Virtual screening for R-groups, including predicted pIC50 contributions, within large structural databases, using Topomer CoMFA.
Cramer RD; Cruz P; Stahl G; Curtiss WC; Campbell B; Masek BB; Soltanshahi F
J Chem Inf Model; 2008 Nov; 48(11):2180-95. PubMed ID: 18956863
[TBL] [Abstract][Full Text] [Related]
35. HierVLS hierarchical docking protocol for virtual ligand screening of large-molecule databases.
Floriano WB; Vaidehi N; Zamanakos G; Goddard WA
J Med Chem; 2004 Jan; 47(1):56-71. PubMed ID: 14695820
[TBL] [Abstract][Full Text] [Related]
36. Efficient method for high-throughput virtual screening based on flexible docking: discovery of novel acetylcholinesterase inhibitors.
Mizutani MY; Itai A
J Med Chem; 2004 Sep; 47(20):4818-28. PubMed ID: 15369385
[TBL] [Abstract][Full Text] [Related]
37. Homology model-based virtual screening for GPCR ligands using docking and target-biased scoring.
Radestock S; Weil T; Renner S
J Chem Inf Model; 2008 May; 48(5):1104-17. PubMed ID: 18442221
[TBL] [Abstract][Full Text] [Related]
38. Bayesian screening for active compounds in high-dimensional chemical spaces combining property descriptors and molecular fingerprints.
Vogt M; Bajorath J
Chem Biol Drug Des; 2008 Jan; 71(1):8-14. PubMed ID: 18069988
[TBL] [Abstract][Full Text] [Related]
39. A kinase-focused compound collection: compilation and screening strategy.
Sun D; Chuaqui C; Deng Z; Bowes S; Chin D; Singh J; Cullen P; Hankins G; Lee WC; Donnelly J; Friedman J; Josiah S
Chem Biol Drug Des; 2006 Jun; 67(6):385-94. PubMed ID: 16882313
[TBL] [Abstract][Full Text] [Related]
40. Using consensus-shape clustering to identify promiscuous ligands and protein targets and to choose the right query for shape-based virtual screening.
Pérez-Nueno VI; Ritchie DW
J Chem Inf Model; 2011 Jun; 51(6):1233-48. PubMed ID: 21604699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
